NCT05571618View on ClinicalTrials.gov

The Rechallenge of ADCs in MBC Patients

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

January 1, 2025

Study Completion Date

March 1, 2025

Conditions
Breast Cancer
Interventions
DRUG

ADC

Patients with prior exposure to ADC (either in the adjuvant setting or metastatic disease are allowed).

Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER